Company Filing History:
1 out of 10 
1 out of 34 Years Active: 2024
Title: Seyed Amir Hosseini: Innovator in Cancer Treatment
Introduction
Seyed Amir Hosseini is a notable inventor based in Milan, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on the development of combinational therapies that enhance the effectiveness of cancer treatments.
Latest Patents
Seyed Amir Hosseini holds a patent for the "Use of a combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer." This patent outlines methods for treating cancer, including those resistant to LSD1 inhibitors. The approach involves administering an effective amount of a cell cycle inhibitor, such as a CDK4/6 inhibitor or a p21 enhancer, alongside an LSD1 inhibitor to improve treatment outcomes.
Career Highlights
Throughout his career, Seyed Amir Hosseini has worked with esteemed organizations, including the Istituto Europeo di Oncologia and the Università degli Studi di Milano. His research has contributed to advancements in cancer therapies, showcasing his commitment to improving patient outcomes.
Collaborations
Seyed Amir Hosseini has collaborated with prominent colleagues in his field, including Saverio Minucci and Pier Giuseppe Pelicci. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer treatments.
Conclusion
Seyed Amir Hosseini's work in cancer treatment exemplifies the impact of innovative research and patenting in the medical field. His contributions continue to pave the way for advancements in therapeutic strategies against cancer.